United We TransformCreate teamsGrade your agenda
Atlas/Events/AAPA Annual Conference
broadcast-heavy conference agenda analysis

AAPA Annual Conference

This broadcast-heavy conference in Trade Show / Expo shows 20 visible agenda rows from aapa2026.eventscribe.net and scores 29/100: a weak visible outcome architecture. The clearest public signals sit in Personalization and Evidence Maturity; the main limits are Follow Through and Network Design. Visible mechanisms include Participant work, Network design, Learning transfer, and Personalization. The public record does not show follow-up or tracking, so the score should be read as design intent rather than durable... A practical reading: For a reader, this is a comparison record more than a model to copy: it reads as a broadcast-heavy conference, with the strongest visible signal in personalization and evidence maturity and the biggest open question around follow through and network design. The practical test is whether the published agenda connects the room to post-event continuation and evidence. This page is an original public-evidence analysis, not a copy of the source agenda or an endorsement of the event. The score places the visible agenda in the weak visible effectiveness evidence band. The strongest visible pillars are Personalization, Evidence Maturity, and Future-of-Work Fit; the thinnest visible pillars are Follow Through, Network Design, and Participation Architecture. Visible mechanisms include Participant work, Network design, Learning transfer, and Personalization. The extracted agenda preview includes 40 visible rows. The most common formats are Presentation, Unknown, and Meal; the most common inferred purposes are Knowledge Transfer, Unknown, and Pacing.

Primary source evidence: aapa2026.eventscribe.net ↗

Eight-pillar fingerprint

Hover any pillar to see what it measures and, where it scored low, what the agenda is missing.

Participation Architecture?30
Participation Architecture - 30/100. Participant work, contribution, interaction, and alternatives to passive broadcast.Missing: Turn passive airtime into participant work: practice, sensemaking, decisions, critique, or artifact creation.
Follow Through?5
Follow Through - 5/100. Owners, dates, commitments, progress checks, and accountability after the room.Missing: Add named owners, dates, implementation checkpoints, and a visible post-event continuation path.
Problem Specificity?35
Problem Specificity - 35/100. A clear costly problem, objective, decision, or performance target.
Personalization?55
Personalization - 55/100. Role, path, goal, preparation, or connection tailoring for participants.
Network Design?24
Network Design - 24/100. Structured weak ties, bridge-building, mixers, and relationship persistence.Missing: Replace generic networking blocks with designed introductions, ask-offer exchanges, peer groups, or bridge-building rituals.
Learning Transfer?32
Learning Transfer - 32/100. Applied practice, feedback, workplace use, refreshers, and 30-90 day transfer.
Evidence Maturity?45
Evidence Maturity - 45/100. Baseline, comparison, follow-up, isolation, and attribution confidence.
Future-of-Work Fit?40
Future-of-Work Fit - 40/100. Value against time, hybrid reality, accessibility, AI, and meeting load.

Fix the gaps

Field-tested exercises matched to this agenda's weakest pillars, from the exercise library.

Follow Through (5/100)

Exercises that strengthen it: Mental Toughness Workshop • WorkshopBank · 15% Solutions • WorkshopBank · Network Patches

Participation Architecture (30/100)

Exercises that strengthen it: Make A World · Awestruck 3 Minutes · Spectrum Mapping

Agenda Preview

The actual agenda we captured. Every block is classified by format and purpose. Open any block to see how we read it; the colored edge shows whether it is participant work, broadcast, logistics, or a showcase.

Room vs wrapper

5 percent of the 40 classified blocks put participants to work; the rest broadcast, show, or handle logistics. That mix is what drives the participation score.

2
34
4
Participant workBroadcastShowcaseLogistics
8:00 AM - 9:00 AMNarrowing Care Gaps in the HIV Care ContinuumPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
8:00 AM - 9:00 AMWorth the Wait: Powerful Progress in Weight ManagementPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:45 AM - 12:45 PMAxsome Therapeutics Product TheaterPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:45 AM - 12:45 PMFrom Awareness to Action: Elevating the Vaccine Conversation for IMD PreventionPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:45 AM - 12:45 PMLearn About a Nonhormonal FDA-Approved Treatment for Moderate to Severe Vasomotor Symptoms Due to MenopausePresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:45 AM - 12:45 PMWhen Patients with Hypothyroidism Speak, Are We Listening? A Personalized Approach to Care With NP Thyroid®PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
8:00 AM - 9:00 AMPeer insights about a once-daily oral treatment option for adult patients with obesity or with overweight in the presence of at least one weight-related comorbidityPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
8:00 AM - 9:00 AMXolair (Omalizumab): A Therapeutic Option For IgE-Mediated Food AllergiesPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
12:30 PM - 1:30 PMImproving Public Health: The Leading Role of Physician Assistants in Adult VaccinationPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
12:30 PM - 1:30 PMLearn About a PrEP Injectable OptionPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
12:30 PM - 1:30 PMPerspectives in Hyperglycemia Secondary to Hypercortisolism - A Path to DiagnosisPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
12:30 PM - 1:30 PMShifting to an Inhaled Corticosteroid-Containing Asthma Rescue ApproachPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
8:00 AM - 9:00 AMProtein Science and Patient Health: Translating Evidence into Clinical PracticeWorkshopParticipant work+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisParticipant work is implied by the formatInferred from format
8:00 AM - 9:00 AMTirzepatide: A Dual GIP and GLP-1 Receptor Agonist (Breakfast Included)MealPacing+
Format · LogisticsMealA pacing block. Can carry unstructured networking, not scored as participant work.
Evidence basisOutcome inferred from formatInferred from format
12:00 PM - 1:00 PMAn Oral Nonopioid Therapy for Treating Acute PainPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
12:00 PM - 1:00 PMScreen + Detect Cancer Early: How the Cologuard Plus® and Cancerguard® tests can help you expand early detection with confidence (Breakfast Included)MealPacing+
Format · LogisticsMealA pacing block. Can carry unstructured networking, not scored as participant work.
Evidence basisOutcome inferred from formatInferred from format
12:00 PM - 1:00 PMSticking it to COVID-19: Updates on the Disease and a Vaccine Option from BioNTech and PfizerPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
12:00 PM - 1:00 PMThe First Signs Matter: Detecting and Treating Early Symptomatic Alzheimer’s DiseasePresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:45 AM - 12:45 PMDiscovering hidden dangers: The critical link between CKD, albuminuria, and cardiovascular riskPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
11:45 AM - 12:45 PMThe healthcare provider’s role in improving adult protection against pneumococcal diseasePresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
8:00 AM - 9:00 AMNarrowing Care Gaps in the HIV Care ContinuumUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
8:00 AM - 9:00 AMWorth the Wait: Powerful Progress in Weight ManagementUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
11:45 AM - 12:45 PMAxsome Therapeutics Product TheaterUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
11:45 AM - 12:45 PMFrom Awareness to Action: Elevating the Vaccine Conversation for IMD PreventionUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
11:45 AM - 12:45 PMLearn About a Nonhormonal FDA-Approved Treatment for Moderate to Severe Vasomotor Symptoms Due to MenopauseUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
11:45 AM - 12:45 PMWhen Patients with Hypothyroidism Speak, Are We Listening? A Personalized Approach to Care With NP Thyroid®UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
8:00 AM - 9:00 AMPeer insights about a once-daily oral treatment option for adult patients with obesity or with overweight in the presence of at least one weight-related comorbidityUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
8:00 AM - 9:00 AMXolair (Omalizumab): A Therapeutic Option For IgE-Mediated Food AllergiesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
12:30 PM - 1:30 PMImproving Public Health: The Leading Role of Physician Assistants in Adult VaccinationUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
12:30 PM - 1:30 PMLearn About a PrEP Injectable OptionUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
12:30 PM - 1:30 PMPerspectives in Hyperglycemia Secondary to Hypercortisolism - A Path to DiagnosisUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
12:30 PM - 1:30 PMShifting to an Inhaled Corticosteroid-Containing Asthma Rescue ApproachUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
8:00 AM - 9:00 AMProtein Science and Patient Health: Translating Evidence into Clinical PracticeWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisHighRead from source
8:00 AM - 9:00 AMTirzepatide: A Dual GIP and GLP-1 Receptor Agonist (Breakfast Included)MealWellbeing+
Format · LogisticsMealA pacing block. Can carry unstructured networking, not scored as participant work.
Evidence basisHighRead from source
12:00 PM - 1:00 PMAn Oral Nonopioid Therapy for Treating Acute PainUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
12:00 PM - 1:00 PMScreen + Detect Cancer Early: How the Cologuard Plus® and Cancerguard® tests can help you expand early detection with confidence (Breakfast Included)MealWellbeing+
Format · LogisticsMealA pacing block. Can carry unstructured networking, not scored as participant work.
Evidence basisHighRead from source
12:00 PM - 1:00 PMSticking it to COVID-19: Updates on the Disease and a Vaccine Option from BioNTech and PfizerUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
12:00 PM - 1:00 PMThe First Signs Matter: Detecting and Treating Early Symptomatic Alzheimer’s DiseaseUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
11:45 AM - 12:45 PMDiscovering hidden dangers: The critical link between CKD, albuminuria, and cardiovascular riskUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source
11:45 AM - 12:45 PMThe healthcare provider’s role in improving adult protection against pneumococcal diseaseUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisHighRead from source

The Full Reading

Why It Ranks This Way +

Calibrated from GES design 33/100 and verified 33/100 with no fourth-loop cap.

Reader Takeaway. For a reader, this is a comparison record more than a model to copy: it reads as a broadcast-heavy conference, with the strongest visible signal in personalization and evidence maturity and the biggest open question around follow through and network design. The practical test is whether the published agenda connects the room to post-event continuation and evidence.

Strongest signals: Personalization, Evidence Maturity, and Future-of-Work Fit. Weakest signals: Follow Through, Network Design, and Participation Architecture.

How This Agenda Could Improve +
  • Add named owners, dates, implementation checkpoints, and a visible post-event continuation path.
  • Replace generic networking blocks with designed introductions, ask-offer exchanges, peer groups, or bridge-building rituals.
  • Turn passive airtime into participant work: practice, sensemaking, decisions, critique, or artifact creation.

Fastest next move: Add named owners, dated next steps, and a visible continuation path before treating the event as outcome-ready.

Role-Specific Reading +

Event owner lens

Use this record to benchmark whether a comparable event makes the work after the room visible. The score is 29/100, so the next move is to benchmark the weakest pillars before repeating the format.

Sponsor lens

Look beyond exposure. Strong sponsor value would show qualified interaction, problem work, buyer learning, customer evidence, or follow-up. The practical sponsor move is to look for structured introductions, buyer-seller fit, and relationship persistence.

Designer lens

The agenda is useful as a pattern sample from aapa2026.eventscribe.net. Redesign attention should go first to the lowest-scoring pillars; in practice, turn the thinnest agenda blocks into participant work.

Executive lens

Treat the visible agenda as an operating plan. The executive move is to require owners, dates, and evidence before treating the event as strategic. If owners, proof, and follow-through are not visible, the public record does not yet prove strategic movement.

Aggregator lens

Treat the source URL as evidence, not decoration. The data-product move is to label the source boundary clearly before ranking the record before ranking or syndicating the record.

What GES Means Here +

The Gathering Effectiveness Score is a strict 0-100 public-evidence reading of the agenda across eight pillars. It rewards visible participant work, follow-through, transfer, network design, and proof mechanisms more than polish, speaker fame, attendance, or satisfaction.

Visible mechanisms: Participant work, Network design, Learning transfer, Personalization.

Evidence boundary: Scores reflect visible agenda/source evidence and should not be read as proof of causal event impact.

Limitations, Score Caps, and Review Flags +

Limitations

  • No visible follow-up, progress monitoring, or longitudinal tracking.
  • Passive stage formats dominate the visible agenda.
  • No baseline measurement is visible.

Score caps

  • No fourth-loop score cap applied.

Review flags

  • No source-backed follow-up, validation, baseline, tracking, or impact evidence.
  • No tracking, validation, feedback, or impact measurement found in the visible source text.
  • Original category was unknown; publication category is inferred.
Is this proof the event worked? +

No. This is a strict public-evidence reading of the agenda. Proof would require baseline, comparison, follow-up, attribution, and impact evidence beyond the listing.

What should a reader inspect first? +

Start with the source URL, then compare the eight pillar scores against the agenda rows. The biggest opportunities usually sit in follow-through, evidence maturity, and participant work.

Why publish weak records? +

Weak records are part of the map. They show where public agendas still describe sessions and speakers more often than outcomes, commitments, transfer, or proof.

How should I use the rows? +

Read the agenda rows as the visible design trace: formats, purposes, and evidence labels show what the public source made inspectable, not everything that happened in the room. This is a source-grounded interpretation of the public agenda record, not a copy of the source, and not an endorsement of the event.

Where To Go Next

Compare this agenda against other Trade Show / Expo events scored on the same eight pillars.